Opiate effects on in vitro human retroviral infection

Advances in Experimental Medicine and Biology

Volumn 437, Issue , 1998, Pages 91-100

  Nyland, Susan Bell ^a   Specter, Steven ^a   Im Sin, Jeong ^a   Ugen, Kenneth E ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE AGONIST; OPIATE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DISEASE TRANSMISSION; DRUG ABUSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOMODULATION; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RETROVIRUS INFECTION;

HTLV; HTLV 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; SIMIAN IMMUNODEFICIENCY VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0031857145     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5347-2_11     Document Type: Conference Paper

References (20)

1. E. Feigal, E. Murphy, K. Vranizian, P. Bacchetti, R. Chaisson, J. Drummond , W. Blattner, A. McGrath, R. Greespan, and A. Moss, Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity. Journal of Infectious Diseases; 164: 36-42 (1991)
2. M. G. Agadjanyan, K.E. Ugen, B. Wang, W. V. Williams, and D. B. Weiner, Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection. Journal of Virology; 68:485-493 (1994)
3. H. W. Haverkos and W. R. Lange, Serious infections other than human immunodeficiency virus among intravenous drug abusers. J. Infect. Dis., 161: 894-902 (1990)
4. S. G. Sandler, F. Fang, and A. Williams, Retroviral infections transmitted by blood transfusions. Yale Journal Biol. Med., 63: 353-360 (1990)
5. J. Madden, A. Falek, R. Donahoe, D. Ketelson, and C. L. Chappel, Opiate binding sites on cells of the immune system. NIDA Research Monographs, 105: 103-108 (1991)
6. R. J. McDonough, J. Madden, A. Falek, D. A. Shafer, M. Plin, D. Gordon, P. Bokas, J. C. Kuehnle, and J. Mendelson, Alterations of T and null lymphocyte frequencies in peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on lymphocytes. J. Immunol., 125:2539-2545 (1980)
7. N. P. Plotnikoff, R. E. Faith, A. J. Murgo, R. B. Herberman, and R. A. Good, Methionine Enkephalin: A New Cytokine - Human Studies. Clinical Immunology and Immunopathology, 82: 93-101 (1997)
8. J. I. Sin, N. Plotnikoff, and S. Specter, Anti-retroviral activity of methionine enkephalin and AZT in a murine cell culture. Int. J. Immunopharmacology, 18: 305-310 (1996)
9. V. A. Johnson and R. E. Byington, Quantitative Assays for Virus Infectivity. In: "Techniques in HIV Research" 71-76, A. Aldovini and B.D. Walker, Ed, Stockton Press (1990).
10. J. A. Zack, J. Cann, J. P. Lugo, I. S. Chen, HIV-1 production from infected peripheral blood T cells after HTLV-1 induced mitogenic stimulation. Science, 240: 1026-1029 (1988)
11. S. Noe, S. B. Nyland, K. E. Ugen, R. Widen, H. Friedman, and T. W. Klein, Cannabanoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-IMN. In: "Drugs of Abuse, Immunomodulation, and AIDS" H. Friedman, J. Madden, and T. Klein, Eds., Plenum Publishing Corporation (1997) (In Press)
12. L. F. Chuang, K. F. Killam, and R. Y. Chuang, Increased replication of simian immunodeficiency virus in CEMx174 cells by morphine sulfate, Biochem. Biophys Res. Comm., 195: 1165-1173 (1993)
13. T. Zhu, H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho, Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science, 261:1179-1181 (1993)
14. A. I. Spira, P. A. Marx, B. K. Patterson, J. Mahoney, R. A. Koup, S. M. Wolinsky and D. D. Ho, Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med., 183: 215-225 (1996)
15. M. Cornelissen, G. Mulder-Kampinga, J. Veenstra, F. Zorgdrager, C. Kuiken, S. Hartman, J. Dekker, L. van der Hoek, C. Sol, R. Coutinho, and J. Goudsmit, Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J. Virology, 69:1810-1818 (1995)
16. P. K. Peterson, B. Sharp, G. Gekker, P. S. Portoghese, K. Sannerud, and J. Balfour, Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS, 4: 869 (1990)
17. P. K. Peterson, G. Gekker, S. Hu, W. R. Anderson, F. Kravitz, P. S. Portoghese, H. H. Balfour jr., and C. C. Chao, Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J. Neuroimmunology, 50: 167-175 (1994)
18. H. H. Loh and A. P. Smith, Regulation of acute and chronic opioid receptor functions by OBCAM, a cell adhesion-like molecule, NIDA Research Monograph 161: Molecular Approaches to Drug abuse Research, Ed: Theresa N. H. Lee, 141-152 (1996)
19. M. Minami and M. Satoh, Molecular biology of the opioid receptors: structures, functions and distributions. Neuroscience Research, 23: 121-145 (1995)
20. A. Hachisuka, T. Yamazaki, J. I. Sawada, and T. Terso, Characterization and tissue distribution of opioid-binding cell-adhesion molecule (OBCAM) using monoclonal antibodies, Neurochemistry International, 28: 373-379 (1996).